IRCT201108073836N2CompletedPhase 3
Efficacy of early Helicobacter Pylori eradication versus continuous pantoprazol infusion in prevention of rebleeding in peptic ulcer patients
Jundishapour Ahvaz University of Medical Sciences0 sites102 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Enrollment
- 102
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 16 years to 89 years (—)
- Sex
- All
Inclusion Criteria
- •The bleeding peptic ulcer patients with age = 16 y old who have stigmata of recent bleeding like active spurting ( Forrest IA), non bleeding visible vessel ( Forrest IIA), oozing or adherent clot with visible vessel ( Forrest IA, IB, IIA) will be included in study. The exclusion criteria are: esophageal varicose, liver cirrhosis, malignancy, concomitant morbidity, cardiac pacemaker, NSAID consumption, current therapy with anti coagulant, antibiotic or PPI and multiple ulcers.
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Recruiting
Not Applicable
Efficacy of Helicobacter pylori Eradication for the Treatment of Immune Thrombocytopenic Purpura (ITP)KCT0003270Seoul National University Bundang Hospital54
Not yet recruiting
Not Applicable
Efficacy of Helicobacter pylori eradication followed by sequential administration of proton pump inhibitor and proton pump inhibitor plus prokinetic for the patients with dyspepsiapatients with dyspepsia and H.pylori infectionJPRN-UMIN000012827Okayama University Hospital200
Recruiting
Not Applicable
Efficacy of tailored Helicobacter pylori eradication therapy based on susceptibility to antimicrobial agentsH. pylori-associated gastritisJPRN-UMIN000030270Shiga University of Medical Science Hospital310
Recruiting
Phase 2
Helicobacter pylori eradication therapy with Vonoprazan, reduced dosage of amoxicillin, and clarithromycin for hemodialysis patientsHelicobacter pylori infectionHelicobacter pyloriJPRN-jRCTs031200237Soichiro Sue23
Recruiting
Phase 2
Helicobacter pylori eradication therapy with vonoprazan, clarithromycin, and metronidazole for chronic kidney disease patientsHelicobacter pyloriHelicobacter pylori infectionJPRN-jRCTs031200239Sue Soichiro24